Revvity stock hits 52-week low at 87.63 USD

Revvity Inc’s stock has reached a new 52-week low, closing at 87.63 USD. According to InvestingPro analysis, the $10.36 billion market cap company appears undervalued at current levels, with a perfect Piotroski Score of 9 indicating strong financial health. This marks a significant downturn for the company, which has experienced a 28.91% decline over the past year, with YTD returns at -21.08%. The stock’s performance reflects broader challenges faced by the company, as it navigates a competitive market environment and potential internal adjustments. Despite the decline, the company maintains strong fundamentals with a current ratio of 3.33, indicating solid liquidity. InvestingPro subscribers have access to 10+ additional key insights about Revvity’s financial position. Investors are closely monitoring Revvity’s strategy and financial health as the company seeks to rebound from its current position. The company maintains an overall "GOOD" Financial Health Score of 2.65 according to InvestingPro’s comprehensive analysis, available in the detailed Pro Research Report.

In other recent news, Revvity Inc. reported its second-quarter 2025 earnings, which surpassed analyst expectations with an adjusted earnings per share of $1.18, compared to the forecasted $1.14. The company’s revenue reached $720 million, exceeding the anticipated $710.39 million. Despite these positive financial results, several analysts have adjusted their price targets for Revvity, citing challenges in the Chinese market. Stifel lowered its price target to $110, maintaining a Hold rating, while Raymond (NSE:RYMD) James reduced its target to $115 with an Outperform rating due to reimbursement headwinds in China. Bernstein also set a new target of $115, noting that Revvity’s organic growth matched consensus estimates. Jefferies further decreased its price target to $100, highlighting concerns over China’s drug-related group policies affecting the company’s financial outlook. These recent developments reflect the complex dynamics Revvity faces in maintaining its growth trajectory amidst external pressures.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.